[1] 陈灏珠,李宗明主编. 内科学[M]. 3版. 北京:人民卫生出版社 1995:428-434. [2] 姚希贤.临床消化病学[M].天津:天津科学技术出版社,1999:498. [3] Grines C L, Bonow R O, Casey D E, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents[J]. Circulation, 2007,115:813-818. [4] Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study[J].BMJ, 2006,333:726-730. [5] Patrono C, Bachmann F, Baigent C, et al. Expert consensus document on use of antiplatelet agents[J]. Eur Heart J, 2004, 25:166-181. [6] CAPRIE Investigators. A randomized, blinded trial of clopidogrel versus asprin in patients at risk of ischeamic events[J]. Lancet, 1996,348:1329-1339. [7] Ng F H, Wong S Y, Chang C M, et al. High incidence of cloidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease[J].Aliment Pharmacol Ther, 2003,18:443-449. [8] Yusuf S, Zhao F, Mehta S R, et al. Effect of colpidogrel in addition to asprin in patients with acute coronary syndromes without ST-segment elevation[J]. N Engl J Med, 2001,345:494-502. [9] Joseph A D, Lucie O, James M B, et al. Drug-drug interaction between antithrombotic medications and the risk of gastrointestinal bleeding[J]. CMAJ,2007,177(4):347-351. [10] Eikelboom J W, Hirsh J. Bleeding and management of bleeding[J]. Eur Heart J, 2006,8:G38-45. [11] CURE Trial Investigators. Effects of aspirin dose when used alone or in combination with colpidogrel in patients with acute coronary syndromes[J]. Circulation, 2003,108:1682-1687. [12] 王世安,孟克,张新民,等.奥美拉唑预防高危患者术后应激性溃疡的体会[J].中华现代外科学杂志,2009,6:363-364. [13] 彭风芹,郭洪涛,苗青,等.洛赛克与雷尼替丁预防冠心病PTCA+STENT术后并发上消化道出血的临床研究[J].现代中西医结合杂志,2003,12:1482-1484. |